AZD8186 First Time In Patient Ascending Dose Study

Clinical trial NCT01884285 · COMPLETED

Trial details

NCT number: NCT01884285
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Castrate-resistant Prostate Cancer CRPC Squamous Non-Small Cell Lung Cancer sqNSCLC Triple Negative Breast Cancer TNBC

Start date: 2013-07-09
Primary completion: 2019-03-31
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.